In celebration of Women’s History Month, we are illuminating the scientific achievements of women in biotechnology and biomedicine.
5 women leaders in biotechnology and biomedicine
read more
Menu
Recent Posts
News Categories
CoBB student Harry Morford bridges the gap between computational biology and clinical care
Meet Harry Morford, a second-year student in the Computational Biomedicine and Biotechnology (CoBB) master’s degree program.
Achyudhan Kutuva earns award to attend Systems Approaches to Cancer Biology Conference
PhD student Achyudhan Kutuva received an award to attend the Systems Approaches to Cancer Biology (SACB) Conference.
Graduate Spotlight: Andrew McNutt, PhD ’24
Andrew McNutt, a recent graduate of the Joint Carnegie Mellon-University of Pittsburgh PhD Program in Computational Biology (CPCB), is making his mark in drug discovery.
Fighting lymphoma inspired alumnus Lidio Meireles to push the boundaries of transplant donor matching
Alumnus Lidio Meireles is leveraging the power of machine learning to find suitable donors for patients seeking stem cell transplants.
Graduate Spotlight: Caroline Larkin, PhD ‘24
CPCB graduate Caroline Larkin is paving her own path and integrating science into the things she loves. The CPCB program helped her to find her research niche at the intersection of biology and virology.
Graduate Spotlight: Ali Tugrul Balci, PhD ‘24
Through the CPCB program, Ali Tugrul Balci discovered both a supportive community and a passion for cutting-edge computational biology research.
Sophia Hu presents research at the International Conference on Systems Biology
PhD candidate Sophia Hu delivered a talk at the 23rd International Conference on Systems Biology (ICSB), which brought together outstanding systems biology researchers from around the world.
Pitt alumnus Arjun Singh advances cancer research at UPMC Hillman Cancer Center
When Arjun Singh was exploring graduate school programs, he knew he wanted a degree that combined his interests in biotechnology and computer science. This led him to Pitt.
Roth lab variant effect map improves understanding of CHEK2 breast cancer risk gene
What if there were a way to improve clinical testing for changes in our genome (variants) that cause increased risk of breast cancer? A research team led by Frederick (“Fritz”) Roth answers this question in an article in the American Journal of Human Genetics.